Michael L. Jones - Mar 1, 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Exec. Director, Finance - PAO
Signature
Michael L. Jones
Stock symbol
BCRX
Transactions as of
Mar 1, 2022
Transactions value $
-$28,681
Form type
4
Date filed
3/3/2022, 04:04 PM
Previous filing
Dec 16, 2021
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $10.9K +2.3K +20.54% $4.73 13.5K Mar 1, 2022 Direct
transaction BCRX Common Stock Sale -$39.6K -2.3K -17.04% $17.20 11.2K Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -2.3K -100% $0.00* 0 Mar 1, 2022 Common Stock 2.3K $4.73 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.